In this setting, G-CSF operates in partnership with tumor-derived neutrophil chemoattractants, most prominently the chemokines CXCL5 (also known as epithelial neutrophil-activating peptide-78; ENA-78) and CXCL8 (IL-8) [92,93]. The gene discussed is CXCL8; the disease is neoplasm.